title: Spinal nerve ligation reduces nitric oxide synthase activity and expression: effect of resveratrol.
abstract: The effect of resveratrol on activity and expression of nitric oxide synthase (NOS) in the spinal cord of neuropathic rats was assessed. Spinal nerve ligation produced tactile allodynia along with a reduction of catalytic activity of the constitutive Ca(2+)-dependent NOS (eNOS and nNOS isoforms) in the ipsilateral dorsal horn, but not contralateral dorsal or ipsilateral or contralateral ventral, spinal cord at 1, 5, 10 and 15 days after surgery compared to naïve and sham-operated animals. Nerve ligation also induced a reduction of nNOS expression in the ipsilateral dorsal horn spinal cord at 10 and 15 days after surgery. Intrathecal resveratrol reduced allodynia and reversed the reduction of constitutive Ca(2+)-dependent NOS activity in the ipsilateral dorsal spinal cord. Moreover, resveratrol significantly reversed the reduction of nNOS expression in the ipsilateral dorsal horn spinal cord. Results show that spinal nerve ligation leads to development of tactile allodynia along with a reduction in constitutive Ca(2+)-dependent NOS activity and nNOS isoform expression in the ipsilateral dorsal horn. Data suggest that resveratrol may reduce tactile allodynia in neuropathic rats by restoring altered NOS activity and expression.
authors.affiliation: Departamento de Neuroquímica, Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suárez", Secretaría de Salud, México, DF, Mexico.
authors.forename: Francisca
authors.initials: F
authors.lastname: Pérez-Severiano
authors.forename: Deysi Y
authors.initials: DY
authors.lastname: Bermúdez-Ocaña
authors.forename: Pedro
authors.initials: P
authors.lastname: López-Sánchez
authors.forename: Camilo
authors.initials: C
authors.lastname: Ríos
authors.forename: Vinicio
authors.initials: V
authors.lastname: Granados-Soto
mesh_terms: D000199:Actins / Q000494:pharmacology; D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D007278:Injections, Spinal; D008026:Ligation; D009569:Nitric Oxide / Q000502:physiology; D052248:Nitric Oxide Synthase Type I / Q000096:biosynthesis*; D010147:Pain Measurement / Q000187:drug effects; D010812:Physical Stimulation; D051381:Rats; D017208:Rats, Wistar; D000077185:Resveratrol; D013116:Spinal Cord / Q000187:drug effects / Q000201:enzymology; D013127:Spinal Nerves / Q000502:physiology*; D013267:Stilbenes / Q000008:administration & dosage / Q000494:pharmacology*
chemical_list: D000199:Actins; D000975:Antioxidants; D013267:Stilbenes; D009569:Nitric Oxide; D052248:Nitric Oxide Synthase Type I; D000077185:Resveratrol